David Foster, president and co-founder of Isla Pharmaceuticals, explains the rationale behind selecting Puerto Rico as a base for the company, which aims to develop treatments for mosquito-borne disease. He highlights Isla Pharmaceuticals’ unique approach of tackling diseases like Dengue fever and reveals plans for conducting follow-up clinical trials in Puerto Rico.
In Puerto Rico it seems that almost everyone has had experience with mosquito-borne illness, either personally or within their family or group of friends
